Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 535,075 | 493,105 | 510,034 | 519,294 | 464,662 |
| Cost of Goods | 322,577 | 301,543 | 342,962 | 385,709 | 320,425 |
| Gross Profit | 212,498 | 191,562 | 167,072 | 133,585 | 144,237 |
| Operating Expenses | 145,956 | 146,198 | 147,856 | 131,859 | 133,911 |
| Operating Income | 67,119 | 45,907 | 20,178 | 2,435 | 10,751 |
| Interest Expense | 34,083 | 33,885 | 34,535 | 34,895 | 36,669 |
| Other Income | 1,788 | 2,882 | 8,880 | 10,571 | 4,160 |
| Pre-tax Income | 34,824 | 14,904 | -5,477 | -21,889 | -21,758 |
| Income Tax | 2,648 | 359 | 1,485 | 144 | 2,186 |
| Net Income Continuous | 32,176 | 14,545 | -6,962 | -22,033 | -23,944 |
| Minority Interests | 17,644 | 7,839 | -16,983 | N/A | -11,948 |
| Net Income | $14,532 | $6,706 | $10,021 | $-22,033 | $-11,996 |
| EPS Basic Total Ops | 0.10 | 0.05 | -0.02 | -0.06 | -0.08 |
| EPS Basic Continuous Ops | 0.22 | 0.10 | -0.05 | -0.15 | -0.16 |
| EPS Diluted Total Ops | 0.10 | 0.04 | -0.03 | -0.06 | -0.08 |
| EPS Diluted Continuous Ops | 0.21 | 0.10 | -0.05 | -0.15 | -0.16 |
| EBITDA(a) | $125,897 | $103,639 | $82,280 | $64,029 | $71,033 |